• <table id="gigg0"></table>
  • west china medical publishers
    Author
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Author "金峰" 6 results
    • 肝素涂層與非肝素涂層動脈過濾器的臨床對比觀察

      目的 對肝素涂層和非肝素涂層動脈過濾器在體外循環術中的應用結果進行對比觀察。方法 80例體外循環心臟直視手術患者隨機分為兩組,每組40例。A組:用肝素涂層動脈過濾器,B組:用非肝素涂層動脈過濾器;并于不同的時間點觀察血小板計數、血紅蛋白、紅細胞壓積、激活凝血時間和過濾器內網在電子顯微鏡下的改變。結果 轉流60分鐘和結束時血小板計數,A組高于B組(P〈0.05)。電子顯微鏡示A組網眼清晰,邊緣清楚,偶見有塊狀過濾物,B組濾網有絮狀物,散在分布于網眼邊緣,模糊不清,堵塞網眼,表明有纖維蛋白聚集,血小板粘附,脫落形成血小板碎片。結論 肝素涂層動脈過濾器能改善其生物相容性。

      Release date:2016-08-30 06:35 Export PDF Favorites Scan
    • Application of Membrane Covered SelfExpanding Metallic Stent for 49 Patients with the Malignant Stricture of Advanced Esophagus and Cardia under Endoscope

      【摘要】目的探索內鏡直視下應用帶膜記憶合金支架對晚期食管、賁門惡性狹窄的介入治療方法。方法2005年1月2009年11月對49例失去手術機會或拒絕手術的晚期食管癌或賁門癌致食管或賁門狹窄患者,行電子胃鏡引導下放置鎳鈦合金支架;對狹窄程度重、胃鏡不能通過者,先行Savary探條擴張再放置支架。結果49例均成功置入支架,解除狹窄有效率達100%。結論內鏡直視下帶膜支架置入操作方法簡便、安全,可改善患者的生存質量,延長生存時間。

      Release date:2016-09-08 09:31 Export PDF Favorites Scan
    • Analysis of clinical efficacy and safety of suturesuspension single hole laparoscopic cholecystectomy and traditional laparoscopic cholecystectomy in the treatment of gallbladder disease

      Objective To compare the clinical efficacy and safety of suturesuspension single hole laparoscopic cholecystectomy and traditional laparoscopic cholecystectomy (LC) in the treatment of gallbladder disease. Methods A total of 86 cases who got treatment in our hospital from February 2014 to July 2015 were collected prospectively, and then 86 cases were divided into 2 groups: 43 cases of control group underwent LC and 43 cases of experimental group underwent suturesuspension single hole laparoscopic cholecystectomy. Clinical efficacy and safety of the two groups were compared. Results ① Complication. No one suffered from bile duct injury, bile leakage, bile duct stricture, and umbilical hernia; but there were 2 cases suffered from complications in control group, including 1 case of abdominal pain and 1 case of bloating, and the morbidity was 4.65% (2/43). The morbidity of experimental group was 0, there was no significant difference between the 2 groups in the morbidity (P>0.05). During the follow-up period, 1 case suffered from long-term compilation in experimental group, and 2 cases in normal group, there was no significant difference in the long-term complication between the 2 groups (P>0.05). ② Operation and hospitalization. The blood loss and operation time in the experimental group were lower than those of the control group (P<0.05), but there was no significant difference in the hospital stay and hospitalization cost between the 2 groups (P>0.05). ③ Postoperative electrolytes, liver and kidney function. The levels of Na+ and K+ in the experimental group were higher than those of the control group (P<0.05), and the levels of alanine aminotransferase and aspartate aminotransferase were lower than those of control group (P<0.01), but there was no significant difference in the blood urea nitrogen and serum creatinine between the 2 groups (P>0.05). ④ The recovery of gastrointestinal function after surgery. The anal exhaust time and bowel sounds recovery time in experimental group were shorter than those of the control group (P<0.01). Conclusion Suturesus-pension single hole laparoscopic cholecystectomy in the treatment of gallbladder disease is safe, effective, and minimally invasive, and it has little disturbance on gastrointestinal function and liver function, which is worthy of clinical application.

      Release date:2017-04-01 08:56 Export PDF Favorites Scan
    • Combined Therapy of Mosapride and Compound Digestive Enzymes for Functional Dyspepsia

      【摘要】 目的 觀察莫沙必利聯合復方消化酶膠囊治療功 能性消化不良的臨床療效和安全性。方法 2008年1月—2009年7月對62例功能 性消化不良患者隨機分為兩組,每組31例,兩組均口服莫沙必利片,三餐飯前30 min服用5 mg;試驗組加服復方消化酶膠囊,進餐后30 min服用1粒。4周后觀察療 效。結果 試驗組治療總有效率明顯優于對照組,分別為87.1%和61.3%(Plt;0 05)。對上腹痛、餐后飽脹、早飽、上腹燒灼感癥狀改善情況進行比較,試驗 組治療前后的癥狀總積分及癥狀改善有效率與對照組比較差異有統計學意義( Plt;005),而且起效時間明顯縮短。兩組患者均未發現嚴重不良反應。結論 莫沙必利聯合復方消化酶膠囊治療功能性消化不良安全有效,其療效明顯優于 單用促動力藥莫沙必利。

      Release date:2016-09-08 09:37 Export PDF Favorites Scan
    • 3例原發性乳腺惡性淋巴瘤的診斷和治療

        病例1 女,48歲,因發現右乳腺無痛性腫物1個月入院。查體: 雙乳腺大小形態對稱,右乳腺內上象限捫及1個2.5 cm×2.5 cm大小的腫物,圓形,表面光滑,與皮膚無粘連,質中等,活動好,無壓痛,雙腋下淋巴結未及。彩超: 右乳腺內上象限實質性占位,無完整包膜,內有少許血流信號; 鉬靶檢查: 右乳腺內上象限邊緣光滑的等密度腫物,無明顯鈣化影。X線和B超未見異常。行右乳腺腫物切除術,術中冰凍切片: 可見增生的淋巴樣細胞,無上皮樣結構,惡性不除外。術后病理報告: 黏膜相關淋巴組織型邊緣區B細胞淋巴瘤。免疫組化CK(-)、EMA(-)及CD20(+)。行CHOP方案化療,共6個療程,并直線加速器放療1個療程,隨訪7年,無復發。  病例2 女,69歲,因右乳腺無痛性腫物3個月入院。查體: 雙乳腺形態大小對稱,右乳腺外上象限捫及1個1.5 cm×1.5 cm分葉狀腫物,質中等,偏硬,邊界清楚,與皮膚無粘連,活動好,無壓痛,雙腋窩淋巴結未及。彩超: 右乳腺外上象限實質性占位,有少許血流信號; 鉬靶檢查: 右乳腺外上象限中等密度分葉狀腫物,邊緣清,內部分布均勻,無鈣化。X線和B超未見異常。行右乳腺腫物切除,術中冰凍切片: 淋巴細胞密集增生,無上皮樣結構。術后病理報告: 黏膜相關淋巴組織型邊緣區B細胞淋巴瘤。免疫組化LCA(+)、CD20(+)、CD40(-)及EMA(-),分期為Ⅱa期,行二期右乳腺癌改良根治術,腋窩淋巴結轉移4/19。行CHOP方案化療,共6個療程,并直線加速器放療1個療程,隨訪第5年復發,全身器官淋巴瘤浸潤,全身衰竭死亡。  病例3 女,52歲,發現右乳腺無痛性腫物1個月,腫物破潰1周入院。查體: 右乳腺外上象限捫及1個4.5 cm×4.5 cm大小的腫物,圓形,表面光滑,與皮膚粘連,中央破潰,有少許膿性分泌物,邊界清,壓痛陽性,左乳腺正常。右腋下捫及有3枚腫大淋巴結,質硬,活動好。彩超: 右乳實質性占位,內有少許血流信號; 鉬靶檢查: 右乳腺圓形巨大包塊,邊界清,無鈣化,右腋下可見腫大淋巴結。X線和B超未見異常。行右乳腺腫物切除術,術中快速切片提示: 右乳腺淋巴癌可能。術后病理提示: 黏膜相關淋巴組織型邊緣區B細胞淋巴瘤。免疫組化CK(-)、EMA(-)及CD20(+)。術后行CHOP方案化療6個療程和放療1個療程,2年后復發,全身器官淋巴瘤浸潤,全身衰竭死亡。  討論  本病臨床診斷有一定難度,臨床表現、查體、B超、X線特征與乳腺癌、乳腺纖維瘤均難鑒別。大部分病例術中冰凍切片檢查也不能確診,只能看到乳腺腺體內有增生的淋巴樣細胞,必須依靠常規病理及免疫組化才能確診及分型。病理中非霍奇金淋巴瘤占絕大多數,多為B細胞來源。組織學上淋巴樣細胞可排列成串狀,類似經典浸潤性小葉癌,非霍奇金淋巴瘤鏡下所見易與乳腺未分化癌及髓樣癌相混淆,必須常規免疫組化檢查,而CD20等陽性,臨床上主要為彌漫大B細胞淋巴瘤和黏膜相關淋巴組織型邊緣區B細胞淋巴瘤兩種類型。原發性乳腺惡性淋巴瘤的治療方案目前仍有爭議,但也遵循惡性腫瘤綜合治療的原則,只不過是聯合化療為主,加手術、放療的綜合治療,對于四期可進行術前化療,手術以乳腺腫物局部切除為主,腫物較大者行單乳切除。關于化療方案,我們還是首選CHOP方案,一般4~6個療程,最少堅持6個療程,同時或化療后行1個療程放療。

      Release date:2016-09-08 11:49 Export PDF Favorites Scan
    • Treatment of ventricular septal defect with pulmonary hypertension with entricular septal defect repair and lung allograft: a case report

      Objective To explore the clinical effect of ventricular septal defect repair and lung allograft (simply as "heart repair and lung transplant") in the treatment of ventricular septal defect complicated with severe pulmonary hypertension. Methods A 21-year-old female patient with ventricular septal defect and severe pulmonary hypertension was treated with cardiopulmonary bypass (CPB) under general anesthesia, and then right lung transplantation was performed, and then left lung transplantation was performed after changing body position. Results The operation was conducted successively. The intraoperative CPB support time was 90 minutes, and the blood loss was 2000 mL. Extracorporeal membrane oxygenation was removed on the second day after operation, the ventilator was evacuated on the third day, and the patient recovered and discharged on the 38th day. Postoperative echocardiography showed significant improvement in pulmonary artery pressure. Conclusion For patients with simple congenital heart disease complicated with severe pulmonary hypertension, "heart repair and lung transplant" can improve their quality of life.

      Release date:2023-01-18 06:43 Export PDF Favorites Scan
    1 pages Previous 1 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南